ICAM-1 autoantibodies detected in healthy individuals and cross-react with functional epitopes

Marc L Herman1,2, Eric S Geanes1, Rebecca McLennan1

  • 1Genomic Medicine Center, Children's Mercy Research Institute, Kansas City, MO, United States.

Immunohorizons
|June 25, 2025
PubMed

Insights

Autoantibodies against Intracellular Adhesion Molecule 1 (ICAM-1) increase with age and decrease in inflammatory conditions. These autoantibodies target functional sites and may arise from molecular mimicry, impacting immune regulation.

Area of Science:

  • Immunology
  • Molecular Biology

Background:

  • Intracellular Adhesion Molecule 1 (ICAM-1) is a cell surface glycoprotein crucial for cell interactions and immune responses.
  • Elevated ICAM-1 expression is observed in infections and inflammatory diseases, with anti-ICAM-1 therapies showing clinical success.
  • Naturally occurring autoantibodies play roles in immunoregulation, influencing health and disease states.

Purpose of the Study:

  • To investigate the presence and levels of ICAM-1 autoantibodies across different age groups and disease states.
  • To identify specific epitopes targeted by ICAM-1 autoantibodies and their functional relevance.
  • To characterize the IgG subclass distribution of ICAM-1 autoantibodies and explore potential triggers for their generation.

Main Methods:

  • Quantification of ICAM-1 autoantibody levels in various age groups and disease cohorts.
  • Peptide microarray analysis to map ICAM-1 autoantibody epitopes.
  • Determination of IgG subclass (e.g., IgG2) enrichment for anti-ICAM-1 antibodies.

Main Results:

  • ICAM-1 autoantibody levels demonstrated an age-dependent increase.
  • Lower ICAM-1 autoantibody levels were observed in individuals with inflammatory conditions.
  • Identified epitopes targeted by autoantibodies overlapped with critical ICAM-1 functional binding sites.
  • ICAM-1 autoantibodies were significantly enriched for the IgG2 subclass.

Conclusions:

  • ICAM-1 autoantibodies exhibit a dynamic role in immune regulation, influenced by age and inflammatory status.
  • The targeting of functional ICAM-1 sites by autoantibodies suggests potential modulation of ICAM-1 activity.
  • Enrichment of IgG2 subclass points towards potential triggers like molecular mimicry of bacterial antigens or immune dysregulation.
  • Further understanding of ICAM-1 autoantibodies could offer new therapeutic strategies for inflammatory and autoimmune diseases.